0 items USD 0.00Search
Your search for "globaldata ocular hypertension global clinical trials review h1 2016" gave back 48391 results.
Ocular hypertension is caused by poor drainage of the fluid inside the eye. Essentially, this means that too much fluid enters the eye without being...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Ocular hypertension is caused by poor drainage of the fluid inside the eye. Essentially, this means that too much fluid enters the eye without being...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
Ocular hypertension is caused by poor drainage of the fluid inside the eye. Essentially, this means that too much fluid enters the eye without being...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Ocular Hypertension Treatment market will undergo major...
Catalog:
Arsta
August 2022
Price: USD 3,360.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Ocular Hypertension Treatment market will undergo major...
Catalog:
Arsta
August 2022
Price: USD 3,360.00
Macular edema is the accumulation of fluid in the macular retina or under the retina. Macular edema is an important cause of vision loss.Diabetic...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The global Latisse (Bimatoprost) market size was valued at US$ million in 2023. With growing demand in downstream market, the Latisse (Bimatoprost)...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Summary Anorexia Nervosa Clinical Trials market research report provides the newest industry data and industry future trends, allowing you to...
Catalog:
ICRW
February 2021
Price: USD 2,960.00
The “Carteolol Hydrochloride Eye Drops Industry Forecast” looks at past sales and reviews total world Carteolol Hydrochloride Eye Drops sales in 2022...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Innovation and Clinical Trial Tracking Factbook 2017: An Assessment of the Pharmaceutical Pipeline Summary GBI Research’s latest report, “Innovation...
CBR Pharma Insights
May 2017
Price: USD 2,995.00
The global Latisse (Bimatoprost) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Prostaglandin analogues are a class of drugs that bind to a prostaglandin receptor,it used to treat hypotrichosis of the eyelashes and intraocular...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Bimatoprost (CAS 155206-00-1), also known as Latisse or Lumigan, belongs to a group of drugs called prostamides, which are synthetic structural...
Catalog:
GIR
April 2023
Price: USD 3,480.00
Summary Pulmonary Arterial Hypertension (PAH) Medicine market research report provides the newest industry data and industry future trends, allowing...
Catalog:
ICRW
March 2021
Price: USD 2,960.00
Timolol Maleate Eye Drop is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (e.g., ocular...
Catalog:
LPI
January 2023
Price: USD 3,660.00
